STAT
Your go-to source for the latest news in health, science and medicine. Sign up for STAT+ for exclusive analysis of biotech, pharma, and the life sciences.
Oz mentioned risk coding and prior authorizations as areas he plans to examine in Medicare Advantage.
RFK Jr.’s recent roundtable on regenerative medicine offers some worrying signs about his approach to regulating stem cells.
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
In today's Pharmalittle roundup, an FDA office crunch, Trump's health agency picks advance to a full Senate vote, and more.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The Boston biotech scene's a mess, and Marty…
The latest health news stories of the day.
A new report explores possible best practices for the adoption, use and monitoring of health technologies, including AI, for people with disabilities.
RFK Jr.'s claims on the safety of vaccine safety aren't backed by the data.
Banning FDA ad-comm members who have any conflict of interest might sound good, but look a little closer.
Huseyin Zeyd Koytak and his colleagues analyzed 50 million vaccine-related social media posts to find root causes. They found that misinformation is not the primary reason people question vaccination.
This week on the "Readout LOUD" podcast: the sudden withdrawal of a CDC nominee and what went wrong with Covid policies.
In this edition of STAT's Health Tech newsletter: Medical device makers file safety incident reports late, and more.
Jay Bhattacharya, nominee for National Institutes of Health director, and FDA pick Marty Makary clear key Senate committee.
The latest health news stories you need to read today.
The Maryland Senate voted to allow a state board to extend its mandate for lowering prescription drug costs to all residents.
The White House has pulled the nomination of Dave Weldon as CDC director hours before heh was set to appear for his confirmation hearing.
In the Boston area, three months into the new year, the mood in the biotech industry has soured and the outlook has clouded.
Soleno's "life-changing" drug nears approval decision. It stands a very good chance of winning approval.
In a Q&A, NIH addiction chief Nora Volkow speaks about RFK Jr.'s policy shake-ups, 12-step recovery limits, and why overdose deaths are falling.
A new biotech is raising money to develop a drug believed to be capable of starving cancer cells, based on research out of a lauded cancer researcher’s lab.
In a new National Postdoctoral Association report, 43% of postdocs said Trump administration policies have threatened their positions, while more than one-third said their research is delayed or in jeopardy.…
HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.
Bill Cassidy said RFK Jr. pledged to keep communication lines wide open and to consult with the senator on vaccine policy.
The ACLU, which represents the plaintiffs, says that the Trump administration has "no business dictating what facts are permissible, or dictating what views researchers....can express."
Senators ask if contracts between drugmakers and telehealth companies violate the federal anti-kickback statute.
Why do health experts fear the West Texas measles outbreak may be much larger than reported? For some, it’s a question of simple math.
People with food insecurity as young adults had a 41% higher risk of developing heart disease in middle age, a long-running study found.
This is the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to AI in health and medicine.
The major biotech news of the day, brought to you by The Readout.
Germany's financial markets watchdog is looking at whether Bayer fairly disclosed plans for shareholder approval of a capital increase.
And more of the latest health news stories.
After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its maneuvers related to its asthma inhaler.
MELBOURNE, Fla. — Unlike President Trump's picks to lead other health agencies who established their conservative bona fides during the Covid-19 pandemic, his choice to head the Centers for Disease…
For the Rev. Beth Stotts, death is a natural part of her ministry, where she embraces "humbling and powerful" work of guiding people at the end of life.
Staff cuts at SAMSHA will imperil federal efforts to curb suicides and drug overdose deaths, employees say.
The private sector's role in driving and sustaining women's health innovation has become even more critical, writes Elizabeth Bailey of Foreground Capital.
While covering Covid, science writer Carl Zimmer learned how little we know about air and how it affects disease transmission. He turned that work into his new book, “Air-Borne.”
Roche partnered with Zealand Pharma to license an experimental weight loss drug for $1.65 billion upfront, expanding its obesity pipeline.
It's still unclear the total number of grants, dollars and people affected, but the cuts could be a harbinger of what’s to come at other universities.
The MAHA Commission is made up of agency heads, domestic policy advisers and RFK Jr. advisers, including "MAHA moms," and will study childhood chronic disease.
In a letter to Robert F. Kennedy Jr., 100 former CDC employees say due process was not followed in firing them and seek reinstatement.
Eli Lilly’s rising fortunes tied to its weight loss and diabetes drugs led to a nine-figure payday for its top executive.
Last year, Gilead released data showing that an HIV drug, called lenacapavir, could provide virtually complete protection against infection with just a single injection every six months. The drug, now…
In this edition of STAT Health Tech: New Medicare telehealth data, Google retreats on health equity, and more.
In today's D.C. Diagnosis newsletter: a rundown of the GOP’s stopgap government funding bill and why former NIH director Francis Collins has hired security.
Three U.S. senators are calling on Robert Kennedy Jr. to disclose what he and President Trump discussed with drugmakers
The must-read biotech news stories of the day, brought to you by The Readout.
Richard Sever will be chief scientific and strategy officer of openRxiv, a nonprofit to ensure the future of biomedical preprint servers.
And more health news stories you need to read today.
Arvinas and Pfizer's drug vepdegestrant reduced the risk of tumor progression 40% compared to standard treatment for an ESR1-mutated population.
You can subscribe to this RSS to get more information